AnaptysBio, Inc.
DE ˙ DB ˙ US0327241065
44,23 € ↑0,10 (0,23%)
2026-06-03
AKTIENPREIS
SecurityDE:AN6 / AnaptysBio, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership79,670 shares
Latest Disclosed Value $ 4,418,499
UBS Group AG reports 13.76% increase in ownership of AN6 / AnaptysBio, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 79,670 shares of AnaptysBio, Inc. (DE:AN6) valued at $3,808,226 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 70,032 shares of AnaptysBio, Inc.. This represents a change in shares of 13.76% during the quarter. The current value of the position is $3,523,804 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ANAPTYSBIO COM 032724106 79,670 9,638 13.76 4,418 30.13 0.0001
2026-01-29 2025-12-31 13F ANAPTYSBIO COM 032724106 70,032 -5,230 -6.95 3,395 47.35 0.0006
2025-11-13 2025-09-30 13F ANAPTYSBIO COM 032724106 75,262 -1,197,237 -94.09 2,305 -91.84 0.0004
2025-08-14 2025-06-30 13F ANAPTYSBIO COM 032724106 1,272,499 782,226 159.55 28,249 209.95 0.0049
2025-05-13 2025-03-31 13F ANAPTYSBIO COM 032724106 490,273 453,667 1,239.32 9,114 1,783.06 0.0017
2025-02-14 2024-12-31 13F ANAPTYSBIO COM 032724106 36,606 -32 -0.09 485 -60.55 0.0001
2024-11-14 2024-09-30 13F ANAPTYSBIO COM 032724106 36,638 2,060 5.96 1,227 41.69 0.0003
2024-08-14 2024-06-30 13F ANAPTYSBIO COM 032724106 34,578 -29,588 -46.11 867 -40.07 0.0002
2024-05-13 2024-03-31 13F ANAPTYSBIO COM 032724106 64,166 45,424 242.36 1,445 260.35 0.0004
2024-02-09 2023-12-31 13F ANAPTYSBIO COM 032724106 18,742 1,156 6.57 401 27.30 0.0001
2023-11-09 2023-09-30 13F ANAPTYSBIO COM 032724106 17,586 -17,611 -50.04 316 -55.94 0.0001
2023-08-11 2023-06-30 13F ANAPTYSBIO COM 032724106 35,197 31,693 904.48 716 840.79 0.0002
2023-05-12 2023-03-31 13F ANAPTYSBIO COM 032724106 3,504 -48,287 -93.23 76 -95.26 0.0000
2023-02-08 2022-12-31 13F ANAPTYSBIO COM 032724106 51,791 41,097 384.30 1,605 487.91 0.0006
2022-11-10 2022-09-30 13F ANAPTYSBIO COM 032724106 10,694 -11,431 -51.67 273 -39.20 0.0001
2022-08-10 2022-06-30 13F ANAPTYSBIO COM 032724106 22,125 -25,816 -53.85 449 -62.14 0.0002
2022-05-16 2022-03-31 13F ANAPTYSBIO COM 032724106 47,941 21,375 80.46 1,186 28.49 0.0004
2022-02-14 2021-12-31 13F ANAPTYSBIO COM 032724106 26,566 -1,395 -4.99 923 21.77 0.0003
2021-11-15 2021-09-30 13F ANAPTYSBIO COM 032724106 27,961 23,112 476.63 758 501.59 0.0002
2021-08-13 2021-06-30 13F ANAPTYSBIO COM 032724106 4,849 -37,141 -88.45 126 -86.08 0.0000
2021-05-12 2021-03-31 13F ANAPTYSBIO COM 032724106 41,990 40,340 2,444.85 905 2,413.89 0.0003
2021-02-11 2020-12-31 13F ANAPTYSBIO COM 032724106 1,650 1,164 239.51 36 414.29 0.0000
2020-11-12 2020-09-30 13F ANAPTYSBIO COM 032724106 486 -220 -31.16 7 -56.25 0.0000
2020-07-31 2020-06-30 13F ANAPTYSBIO COM 032724106 706 -148 -17.33 16 33.33 0.0000
2020-05-01 2020-03-31 13F ANAPTYSBIO COM 032724106 854 -543 -38.87 12 -47.83 0.0000
2020-02-14 2019-12-31 13F ANAPTYSBIO COM 032724106 1,397 -35,828 -96.25 23 -98.23 0.0000
2019-11-14 2019-09-30 13F ANAPTYSBIO COM 032724106 37,225 18,170 95.36 1,303 21.10 0.0005
2019-08-14 2019-06-30 13F ANAPTYSBIO COM 032724106 19,055 14,433 312.27 1,076 218.34 0.0004
2019-05-14 2019-03-31 13F ANAPTYSBIO COM 032724106 4,622 -34,762 -88.26 338 -86.55 0.0001
2019-02-14 2018-12-31 13F ANAPTYSBIO COM 032724106 39,384 24,969 173.22 2,513 74.76 0.0011
2018-11-14 2018-09-30 13F ANAPTYSBIO COM 032724106 14,415 10,873 306.97 1,438 470.63 0.0006
2018-08-14 2018-06-30 13F ANAPTYSBIO COM 032724106 3,542 -45,336 -92.75 252 -95.05 0.0001
2018-05-15 2018-03-31 13F ANAPTYSBIO COM 032724106 48,878 33,461 217.04 5,087 227.56 0.0022
2018-02-14 2017-12-31 13F ANAPTYSBIO COM 032724106 15,417 12,614 450.02 1,553 1,484.69 0.0006
2017-11-14 2017-09-30 13F ANAPTYSBIO COM 032724106 2,803 -548 -16.35 98 22.50 0.0000
2017-11-14 2017-06-30 13F/A-1 ANAPTYSBIO COM 032724106 3,351 3,238 2,865.49 80 2,566.67 0.0000
2017-08-14 2017-06-30 13F ANAPTYSBIO COM 032724106 3,351 3,238 80
2017-11-14 2017-03-31 13F/A-1 ANAPTYSBIO COM 032724106 113 113 3 0.0000
2017-05-12 2017-03-31 13F ANAPTYSBIO COM 032724106 113 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.